JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.9 trillion in assets and $317 billion in stockholders’ equity as of September 30, 2023. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally.
JPMorgan analyst Vivek Juneja maintains Bank of America (NYSE:BAC) with a Overweight and lowers the price target from $38 to $34.
JPMorgan lowered Bank of America (NYSE:BAC) price target to $34 Read Post »
JPMorgan analyst Vivek Juneja maintains Truist Financial (NYSE:TFC) with a Neutral and lowers the price target from $50 to $41.
JPMorgan lowered Truist Financial (NYSE:TFC) price target to $41 Read Post »
JPMorgan analyst Vivek Juneja maintains Wells Fargo (NYSE:WFC) with a Neutral and lowers the price target from $49 to $45.
JPMorgan lowered Wells Fargo (NYSE:WFC) price target to $45 Read Post »
JPMorgan analyst Steven Alexopoulos downgrades Comerica (NYSE:CMA) from Overweight to Neutral.
JPMorgan downgrades Comerica (NYSE:CMA) to Neutral rating Read Post »
Morgan Stanley analyst Betsy Graseck maintains JPMorgan Chase (NYSE:JPM) with a Overweight and lowers the price target from $173 to $153.
Morgan Stanley lowered JPMorgan Chase (NYSE:JPM) price target to $153 Read Post »
JPMorgan analyst Matthew Boss maintains Ross Stores (NASDAQ:ROST) with a Overweight and raises the price target from $123 to $124.
JPMorgan raised Ross Stores (NASDAQ:ROST) price target from $123 to $124 Read Post »
JPMorgan analyst Chris Schott maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the price target from $900 to $950.
JPMorgan raised Regeneron Pharmaceuticals (NASDAQ:REGN) price target from $900 to $950 Read Post »
JPMorgan analyst Jimmy Bhullar maintains Marsh & McLennan (NYSE:MMC) with a Neutral and raises the price target from $180 to $181.
JPMorgan raised Marsh & McLennan (NYSE:MMC) price target from $180 to $181 Read Post »
JPMorgan analyst Jimmy Bhullar maintains Progressive (NYSE:PGR) with a Neutral and raises the price target from $130 to $132.
JPMorgan raised Progressive (NYSE:PGR) price target from $130 to $132 Read Post »
JPMorgan maintains Chubb (NYSE:CB) with a Overweight and raises the price target from $239 to $241.
JPMorgan raised Chubb (NYSE:CB) price target from $239 to $241 Read Post »
JPMorgan analyst Jared Dinges upgrades Philip Morris Intl (NYSE:PM) from Neutral to Overweight and raises the price target from $109 to $116.
JPMorgan raised Philip Morris Intl (NYSE:PM) price target from $109 to $116 Read Post »
JPMorgan analyst John Royall downgrades Marathon Petroleum (NYSE:MPC) from Overweight to Neutral and raises the price target from $137 to $149.
JPMorgan raised Marathon Petroleum (NYSE:MPC) price target from $137 to $149 Read Post »